New pill plus chemo aims to tackle tough pancreatic cancer
Disease control
Recruiting now
This Phase 3 trial tests whether adding an experimental oral drug called atebimetinib to a modified chemotherapy regimen helps people with metastatic pancreatic cancer live longer. About 510 adults who have not had prior treatment will receive either the new combination or standa…
Phase: PHASE3 • Sponsor: Immuneering Corporation • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC